MPLT
HEALTHCAREMapLight Therapeutics Inc
Live · NASDAQ · May 9, Close
What's Moving MPLT Today?
No stock-specific AI insight has been generated for MPLT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$29.04
Fundamentals
Trading
MPLT News
15 articles- MapLight Therapeutics to Participate in Upcoming Investor ConferencesYahoo Finance·May 8, 2026
- This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of AprilMotley Fool·May 4, 2026
- MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline ResultsYahoo Finance·May 1, 2026
- We're Hopeful That MapLight Therapeutics (NASDAQ:MPLT) Will Use Its Cash WiselyYahoo Finance·Apr 26, 2026
- What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial DataMotley Fool·Apr 22, 2026
- TD Cowen Initiates on MapLight (MPLT); Says It’s Undervalued on Schizophrenia AloneYahoo Finance·Apr 20, 2026
- MapLight Therapeutics (MPLT): The Best Healthcare Stock Insiders Are BuyingYahoo Finance·Apr 12, 2026
- MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateYahoo Finance·Mar 26, 2026
- MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026Yahoo Finance·Jan 9, 2026
- MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease PsychosisYahoo Finance·Jan 5, 2026
- SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS TherapiesYahoo Finance·Dec 16, 2025
- MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate ProgressYahoo Finance·Dec 4, 2025
- MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesYahoo Finance·Oct 29, 2025
- Sector Update: Health Care Stocks Increase Late AfternoonYahoo Finance·Oct 27, 2025
- MapLight Therapeutics Announces Pricing of Initial Public OfferingYahoo Finance·Oct 26, 2025
All 15 articles loaded
Price Data
52-Week Range
$29.04
Fundamentals
Trading
About MapLight Therapeutics Inc
MapLight Therapeutics, Inc. is an innovative biotechnology company dedicated to developing groundbreaking therapies for serious neurological and psychiatric disorders. Utilizing its proprietary platform, MapLight targets intricate biological pathways to create transformative treatment solutions that enhance patient outcomes. With a commitment to scientific rigor and a promising clinical development pipeline, the company is well-positioned to address critical unmet medical needs, affirming its role as a significant player in the dynamic neurotherapeutics sector.